Scarica l'app Stockscreener
0.193
4.38%
0.0081
Pre-mercato:
.19
-0.003
-1.55%
Precedente Chiudi:
$0.1849
Aprire:
$0.1875
Volume 24 ore:
552.41K
Relative Volume:
1.10
Capitalizzazione di mercato:
$2.13M
Reddito:
$24,000
Utile/perdita netta:
$-78.06M
Rapporto P/E:
-0.00666
EPS:
-28.9956
Flusso di cassa netto:
$-21.81M
1 W Prestazione:
-19.55%
1M Prestazione:
-28.52%
6M Prestazione:
-50.13%
1 anno Prestazione:
-96.14%
Intervallo 1D:
$0.1777
$0.197
Intervallo di 1 settimana:
$0.1648
$0.24
Portata 52W:
$0.1648
$8.40
Catheter Precision Inc. Stock (VTAK) Company Profile
Nome
Catheter Precision Inc.
Settore
Industria
Telefono
973 691 2000
Indirizzo
1670 Highway 160 West, Suite 205, Fort Mill
Confronta VTAK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.193 | 2.07M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
133.57 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.17 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.86 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.74 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.10 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-08-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | Iniziato | Maxim Group | Buy |
Catheter Precision Inc. Borsa (VTAK) Ultime notizie
Catheter Precision, Inc. Receives Ce Mark for LockeT - marketscreener.com
Catheter Precision (VTAK) Achieves CE Mark Approval for LockeT D - GuruFocus
Catheter Precision Receives CE Mark Approval for LockeT Vascular Closure Device - marketscreener.com
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in Europe - Nasdaq
Catheter Precision, Inc. Receives CE Mark for LockeT - The Manila Times
Catheter Precision Unlocks $4.3B European Market with CE Mark: First Orders Already Flowing - Stock Titan
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc Files For Resale Of Up To 12.9 Million Shares Of Common Stock By The Selling StockholdersSEC Filing - marketscreener.com
Catheter Precision Enters Market Offering Agreement - MSN
Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co. IncSEC Filing - marketscreener.com
QHSLab Signals Debt Restructuring - citybiz
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth - TradingView
Breakthrough Patent: How Autonomix Medical's New Nerve-Mapping Tech Could Transform Pain Treatment - Stock Titan
Catheter Precision revenue increases 74% to USD 143K in Q1 2025 - Medical Buyer
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results - The Manila Times
Catheter Precision Q1 Revenue Surges 74% as Clinical Studies Show 94% Accuracy in Heart Procedures - Stock Titan
Catheter Precision Enters Securities Purchase Agreement - TipRanks
Catheter Precision, Inc. Announces $1.5 Million Private Placemen - GuruFocus
Catheter Precision (VTAK) Secures $1.5M Through Private Equity F - GuruFocus
Interim Financial Results - The Manila Times
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | VTAK Stock News - GuruFocus
Catheter Precision (VTAK) Secures $1.5M Through Private Equity Financing | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance - GlobeNewswire
Catheter Precision Finalizes Strategic Cardiac Acquisition - TipRanks
Catheter Precision completes acquisition of Cardionomic heart failure assets - TipRanks
Catheter Precision (VTAK) Subsidiary Acquires Cardionomic's Hear - GuruFocus
Catheter Precision, Inc. Completes Acquisition of Cardionomic Heart Failure Assets - The Manila Times
Medical Breakthrough: Catheter Precision Takes Over Million-Patient Heart Failure Treatment Innovation - Stock Titan
Catheter Precision (VTAK) Reveals Enhanced Clinical Data on VIVO System | VTAK Stock News - GuruFocus
New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference - The Manila Times
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society - The Manila Times
Catheter Precision Inc [VTAK] Director makes an insider purchase of 3 shares worth 1.0. - knoxdaily.com
Catheter Precision to Attend and Participate in the 46th Heart R - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society | VTAK Stock News - GuruFocus
Breakthrough Cardiac Study: Catheter Precision's VIVO System Achieves 94% Accuracy in European Multi-Center Trial - Stock Titan
Catheter Precision to acquire late-stage heart failure treatment assets in development - MSN
Analytical Lens: Exploring Catheter Precision Inc (VTAK)’s Financial Story Through Ratios - DWinneX
Catheter Precision Inc (VTAK) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Can Catheter Precision Inc (VTAK) meet market expectations this quarter? - uspostnews.com
How analysts predict Five9 Inc (FIVN) will perform this quarter? - uspostnews.com
Catheter Precision (VTAK) Acquires Assets for Cardiac Technology Expansion | VTAK Stock News - GuruFocus
Catheter Precision to acquire assets of Cardionomic related to CPNS system - TipRanks
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure - The Manila Times
Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure - marketscreener.com
Breakthrough Heart Failure Treatment Tech With 1M Patient Potential Acquired: Early Clinical Success Revealed - Stock Titan
Catheter Precision Inc. Azioni (VTAK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.66%
Capitalizzazione:
|
Volume (24 ore):